217 related articles for article (PubMed ID: 21504722)
1. A model of threshold behavior reveals rescue mechanisms of bystander proteins in conformational diseases.
Sandefur CI; Schnell S
Biophys J; 2011 Apr; 100(8):1864-73. PubMed ID: 21504722
[TBL] [Abstract][Full Text] [Related]
2. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
3. Misfolded proteins and retinal dystrophies.
Lin JH; Lavail MM
Adv Exp Med Biol; 2010; 664():115-21. PubMed ID: 20238009
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
Tao YX; Conn PM
Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
[TBL] [Abstract][Full Text] [Related]
5. Proteostasis: bad news and good news from the endoplasmic reticulum.
Noack J; Brambilla Pisoni G; Molinari M
Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum proteostasis: a key checkpoint in cancer.
Oakes SA
Am J Physiol Cell Physiol; 2017 Feb; 312(2):C93-C102. PubMed ID: 27856431
[TBL] [Abstract][Full Text] [Related]
7. Chaperoning Endoplasmic Reticulum-Associated Degradation (ERAD) and Protein Conformational Diseases.
Needham PG; Guerriero CJ; Brodsky JL
Cold Spring Harb Perspect Biol; 2019 Aug; 11(8):. PubMed ID: 30670468
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders.
Hou ZS; Ulloa-Aguirre A; Tao YX
Expert Rev Clin Pharmacol; 2018 Jun; 11(6):611-624. PubMed ID: 29851355
[TBL] [Abstract][Full Text] [Related]
9. Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.
Muntau AC; Leandro J; Staudigl M; Mayer F; Gersting SW
J Inherit Metab Dis; 2014 Jul; 37(4):505-23. PubMed ID: 24687294
[TBL] [Abstract][Full Text] [Related]
10. Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases.
Ong DS; Kelly JW
Curr Opin Cell Biol; 2011 Apr; 23(2):231-8. PubMed ID: 21146391
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases.
Adnan H; Zhang Z; Park HJ; Tailor C; Che C; Kamani M; Spitalny G; Binnington B; Lingwood C
PLoS One; 2016; 11(12):e0166948. PubMed ID: 27935997
[TBL] [Abstract][Full Text] [Related]
12. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
Naeem A; Fazili NA
Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
[TBL] [Abstract][Full Text] [Related]
13. Protein misfolding in the endoplasmic reticulum as a conduit to human disease.
Wang M; Kaufman RJ
Nature; 2016 Jan; 529(7586):326-35. PubMed ID: 26791723
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of recognition and retrotranslocation of misfolded proteins in the ER-associated degradation].
Nakatsukasa K
Seikagaku; 2009 Aug; 81(8):700-3. PubMed ID: 19803393
[No Abstract] [Full Text] [Related]
15. Pharmacoperones: targeting therapeutics toward diseases caused by protein misfolding.
Ulloa-Aguirre A; Zariñán T; Conn PM
Rev Invest Clin; 2015; 67(1):15-9. PubMed ID: 25857579
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules.
Ulloa-Aguirre A; Conn PM
Curr Drug Targets; 2016; 17(13):1471-81. PubMed ID: 26953247
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.
Ulloa-Aguirre A; Janovick JA; Brothers SP; Conn PM
Traffic; 2004 Nov; 5(11):821-37. PubMed ID: 15479448
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic Reticulum Stress and Associated ROS.
Zeeshan HM; Lee GH; Kim HR; Chae HJ
Int J Mol Sci; 2016 Mar; 17(3):327. PubMed ID: 26950115
[TBL] [Abstract][Full Text] [Related]
19. Misfolded proteins bind and activate death receptor 5 to trigger apoptosis during unresolved endoplasmic reticulum stress.
Lam M; Marsters SA; Ashkenazi A; Walter P
Elife; 2020 Jan; 9():. PubMed ID: 31904339
[TBL] [Abstract][Full Text] [Related]
20. Protein Misfolding Diseases.
Hartl FU
Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
